SWAN Investors are pleased to announce an investment in Linshom Medical. Linshom is the first to deliver a wearable, FDA-cleared, operating room–quality respiratory profile at the patient bedside, providing predictive early warning of deterioration and enabling timely intervention. This may help reduce preventable rapid response activations, rescue events (codes), ICU transfers, and deaths outside the OR and ICU.